Financials
Financial year 2025
PHARMACIE CHIFA from Schaarbeek, company number BE0705824854, closed financial year 2025 with a result of € 45,897 after tax. For that financial year PHARMACIE CHIFA recorded a gross margin of € 191,053 and equity of € 124,168. Compared with financial year 2024, the result moved from € 40,343 to € 45,897. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 20, 2026.
€ 124,168
▲ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 45,897
▲ 14% vs 2024
Profit after tax over the fiscal year.
€ 56,415
▼ 15% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 40,000 paid out
87 % of the profit went to the shareholders, mostly to AZ PHARMA (100 % of the shares). That is where the money ends up.
People and assets in 2025
€ 121,870
▲ 7% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 666
▼ 40% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 4,779
Loans from banks and other lenders, long and short.
€ 114,096
▼ 14% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 12,083
▲ 62% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 111,578 | € 156,296 | € 182,929 | € 191,053 | ▲ 4% |
| Profit after taxes | € 49,547 | € 40,040 | € 40,343 | € 45,897 | ▲ 14% |
| Equity | € 77,888 | € 117,928 | € 118,272 | € 124,168 | ▲ 5% |
| Total debts | € 148,408 | € 164,017 | € 161,157 | € 170,958 | ▲ 6% |
| Cash | € 53,166 | € 67,471 | € 66,052 | € 56,415 | ▼ 15% |
| Land & buildings | € 4,532 | € 4,424 | € 4,316 | € 4,207 | ▼ 3% |
| Retained profit | € 65,488 | € 105,528 | € 105,872 | € 111,768 | ▲ 6% |
| Dividend | € 0 | € 0 | € 40,000 | € 40,000 | |
| Bank debt | € 7,167 | € 7,167 | € 4,779 | € 4,779 | |
| Balance sheet total | € 226,297 | € 281,945 | € 279,428 | € 295,127 | ▲ 6% |
Key figures of PHARMACIE CHIFA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE CHIFA?
What happened at PHARMACIE CHIFA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 45,897 (▲ 14% vs 2024). Source: NBB ↗
- New establishment in Schaarbeek. KBO
- Oussama Zakmout became a director. NBB
- Ahsene AMALOU became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 49,547 profit in 2022 to € 45,897 profit in 2025.
Paid € 63,925 in corporate taxes since 2022.
Best year ever: 2022, with € 49,547 profit.
Paid out € 80,000 in dividends to the owners in total.
A new publication or filing at PHARMACIE CHIFA? We notify you, reason included.
Follow PHARMACIE CHIFADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of AZ PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE CHIFABehind PHARMACIE CHIFA are Oussama Zakmout and Ahsene AMALOU. The shares are held by AZ PHARMA (100%).
Directors
According to the 2025 annual accounts
Oussama Zakmout
Director
Also active at: PHARMACIE GALLAIT, CENTRE MEDICAL CHIFA, AZ PHARMA, PHARMACIE CITY
since 2018
Ahsene AMALOU
Director
since 2018
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Maarschalk Fochlaan 77
1030 Schaarbeek
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0705.824.854
- VAT number
- BE 0705.824.854
- Registered office
- Maarschalk Fochlaan 77, 1030 Schaarbeek
- Names & denominations
- PHARMACIE CHIFA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 September 2018
- Peppol
- Active · Active since 13 Oct 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels